当前位置:
X-MOL 学术
›
Pediatr. Blood Cancer
›
论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Rituximab and intense chemotherapy in a patient with defective cell mediated immunity due to cartilage-hair hypoplasia and Burkitt lymphoma.
Pediatric Blood & Cancer ( IF 3.2 ) Pub Date : 2020-05-13 , DOI: 10.1002/pbc.28259 Beth A Speckhart 1 , Eric Bugaieski 1 , Reuben Antony 2 , Karen S Fernandez 3
中文翻译:
由于软骨-头发发育不全和伯基特淋巴瘤而导致细胞介导的免疫缺陷的患者使用利妥昔单抗和强烈化疗。
更新日期:2020-05-13
Pediatric Blood & Cancer ( IF 3.2 ) Pub Date : 2020-05-13 , DOI: 10.1002/pbc.28259 Beth A Speckhart 1 , Eric Bugaieski 1 , Reuben Antony 2 , Karen S Fernandez 3
Affiliation
中文翻译:
由于软骨-头发发育不全和伯基特淋巴瘤而导致细胞介导的免疫缺陷的患者使用利妥昔单抗和强烈化疗。